INSIGHTS ON DRUG DEVELOPMENT

• Best-In-Class Nanodevelopment Capabilities

  A highly specialized team excels in creating unique nanoparticles for both small and large molecule APIs. Leveraging cutting-edge technology, they produce nanoformed materials as small as 10 nanometers.

• The History Of Chemical Nomenclature And ACD/Name

  Modern chemical naming requires algorithmic precision to match evolving standards and new compound classes. Up-to-date nomenclature ensures regulatory compliance and seamless workflow integration.

• Walk-Away Monitoring Of Cytotoxicity, Viability, And Apoptosis

  Real-time cell health monitoring reveals how drug dose and timing impact apoptosis, necrosis, and viability. Explore how automated workflows help pinpoint mechanistic toxicity windows.

• Bioprocess Training And Education

  Advance from development to manufacturing with expert-led, hands-on, or virtual courses that strengthen process understanding and scale-up skills designed to support every stage of your molecule’s journey.

• Matrix Approach Enhances Potency Assay Development For ATMPs

  12/22/2025

  Potency assays for ATMPs demand precision. Learn how a matrix approach, regulatory alignment, and advanced technologies can overcome variability and ensure safety throughout the product lifecycle.

• Ask Us Anything: Anmaris Torres On The First Steps In Process Transfer

  7/23/2026

  Anmaris Torres, Process Engineering Team Leader, on why a process transfer starts with a conversation across departments to figure out how to cut cycle time before commercial production begins.

• How To Capture Growth In The Expanding Metabolic Drug Market

  12/2/2025

  Driven by GLP-1 success and rising obesity rates, R&D investment in metabolic disease therapies now rivals oncology, demanding rapid development to overcome market challenges.

• Predicting Food Effects In Oral Drug Delivery Using PBPK Modeling

  7/15/2026

  Learn how integrated PBPK and molecular dynamics modeling predicted an ~11% fed-state Cmax increase for fenofibrate, giving formulation teams earlier, mechanistic insight into food-dependent absorption.

• Accelerating Small Molecule Protein Degrader Development Using High-Content Imaging

  5/6/2026

  High‑content imaging enables rapid discovery and optimization of small‑molecule protein degraders by delivering multiparametric, single‑cell insights that accelerate hit identification, SAR development, and lead advancement.